Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)  Jonathan E. Brammer, MD, Rima Saliba, PhD, Hagop Kantarjian, Deborah Thomas, MD, Jeffrey L. Jorgensen, MD, Sameh Gaballa, MD, Celina Ledesma, BS, Uday R. Popat, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Chitra Hosing, MD, Partow Kebriaei, MD  Biology of Blood and Marrow Transplantation  Volume 21, Issue 2, (February 2015) DOI: 10.1016/j.bbmt.2014.11.093 Copyright © 2015 Terms and Conditions

Figure Biology of Blood and Marrow Transplantation 2015 21, DOI: (10.1016/j.bbmt.2014.11.093) Copyright © 2015 Terms and Conditions